Advertisement
There are many unanswered questions about the safety and effectiveness of a drug used to combat hallucinations and delusions in Parkinson disease patients

Questions Remain About Safety of Parkinson Disease Psychosis Drug

0
Federal government has received high number of reports about deaths among patients taking Nuplazid
The incidence and point prevalence of visual problems in acute stroke survivors are very high

High Rates of Visual Problems Seen in Stroke Survivors

0
Three-quarters have visual problems, including impaired central vision, eye movement abnormalities
Physicians with one or more paid malpractice claims are more likely to leave practice or shift into smaller practice settings

Doctors With Malpractice Claims More Likely to Leave Medicine

0
Physicians with five or more malpractice claims more than twice as likely to go into solo practice
Nonsurgical brain stimulation techniques seem effective for acute treatment of major depressive episodes in adults

Nonsurgical Brain Stimulation Beneficial in Major Depressive Episodes

0
Ten of 18 reviewed treatment strategies linked to higher response versus sham therapy
Lifetime risks for hypertension under the American Heart Association and American College of Cardiology 2017 threshold exceed 75 percent for white men and African-American men and women

Lifetime HTN Risk High for Black Men and Women, White Men

0
Lifetime risks are higher under AHA/ACC 2017 HTN threshold than JNC7 threshold for hypertension
Early life stress caused by childhood maltreatment can alter brain structure

Maltreatment in Childhood May Affect Course of Adult Depression

0
Links found among childhood maltreatment, relapse of depression as an adult, and altered brain structure
One-fifth of infants born with a birth weight less than 400 g survive to 18 to 26 months' corrected age

Infants Born Weighing <400 g Who Survive at Risk for Severe Morbidity

0
One in five infants born at <400 g survives, but neurodevelopmental impairment common
Mayzent (siponimod) pills have been approved by the U.S. Food and Drug Administration for adults with relapsing multiple sclerosis.

FDA Approves Mayzent for Relapsing Multiple Sclerosis

0
Oral medication must be dispensed with important information about the drug's uses and risks
After adjusting for the competing risk of death without dementia

Smoking Seems Not to Be Linked to Increased Dementia Risk

0
No increased risk for dementia observed when adjusting for risk of death without dementia
The 2019 healthiest community in America is Douglas County

Douglas County, Colorado, Ranked as Healthiest Community

0
Seven of top 20 communities were in Colorado; nearly all adults in these counties exercise